GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (LTS:0KHE) » Definitions » Total Liabilities

Revvity (LTS:0KHE) Total Liabilities : $5,586 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Revvity Total Liabilities?

Revvity's Total Liabilities for the quarter that ended in Mar. 2024 was $5,586 Mil.

Revvity's quarterly Total Liabilities declined from Sep. 2023 ($5,727.27 Mil) to Dec. 2023 ($5,691.93 Mil) and declined from Dec. 2023 ($5,691.93 Mil) to Mar. 2024 ($5,586.21 Mil).

Revvity's annual Total Liabilities declined from Dec. 2021 ($7,859.31 Mil) to Dec. 2022 ($6,746.98 Mil) and declined from Dec. 2022 ($6,746.98 Mil) to Dec. 2023 ($5,691.93 Mil).


Revvity Total Liabilities Historical Data

The historical data trend for Revvity's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Total Liabilities Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,724.74 4,224.82 7,859.31 6,746.98 5,691.93

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,604.35 6,348.59 5,727.27 5,691.93 5,586.21

Revvity Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Revvity's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1450.463+(3310.517+930.946
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=5,692

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=13564.665-7872.739
=5,692

Revvity's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1374.222+(3292.192+919.795
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=5,586

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=13432.705-7846.496
=5,586

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revvity Total Liabilities Related Terms

Thank you for viewing the detailed overview of Revvity's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (LTS:0KHE) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity (LTS:0KHE) Headlines

No Headlines